Methenamine mandelate 100 MG/ML Oral Solution — RxCUI 2741045
RxNorm drug concept · Semantic clinical drug
RxCUI 2741045
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2741045
Official nameMethenamine mandelate 100 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmethenamine mandelate 500 MG per 5 ML Oral Solution; methenamine mandelate 500 MG in 5 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Methenamine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- That's a great question. Methenamine isn't used to clear an active infection — it's used to prevent another one from taking hold. Once your other antibiotic has done that job, meth...
- Why do I need to take methenamine if my infection is already gone?
- Yes, it actually does. Methenamine only converts into its active antibacterial form in acidic urine. Foods and medications that make your urine more alkaline — less acidic — can re...
- Does it matter what I eat or drink while I'm on this medication?
🕸️ Concept Web — How Methenamine mandelate 100 MG/ML Oral Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Methenamine mandelate 100 MG/ML Oral Solution
RxCUI 2741045 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Methenamine
6832IN -
Methenamine mandelate
161623PIN
-
Methenamine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Methenamine Oral Solution
2741043SCDF -
Methenamine mandelate Oral Solution
2741044SCDFP -
Methenamine Oral Liquid Product
1162214SCDG -
Methenamine Oral Product
1162215SCDG -
Methenamine mandelate Oral Liquid Product
2660435SCDGP -
Methenamine mandelate Oral Product
2661378SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Methenamine Oral Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Methenamine mandelate 100 MG/ML
1000023SCDC
-
Methenamine mandelate 100 MG/ML
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Methenamine mandelate 100 MG/ML
SCDC · 1000023 -
Methenamine Oral Solution
SCDF · 2741043 -
Methenamine mandelate Oral Solution
SCDFP · 2741044 -
Methenamine Oral Liquid Product
SCDG · 1162214 -
Methenamine Oral Product
SCDG · 1162215 -
Methenamine mandelate Oral Liquid Product
SCDGP · 2660435 -
Methenamine mandelate Oral Product
SCDGP · 2661378
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2741045 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 85477-0115-16 | 473 mL in 1 BOTTLE (85477-115-16) | Methenamine Mandelate | Oncora Pharma, LLC | 2026-04-20 |
Observed labelers:
Oncora Pharma, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.